Efficacy and safety of triple antiplatelet therapy with and without concomitant anticoagulation during elective percutaneous coronary intervention (the REMOVE trial).

Valencia, Rafael; Price, Matthew J; Sawhney, Neil; Lee, Steve S; Wong, Garrett B; Gollapudi, Raghava R; Banares, Michelle; Schatz, Richard A; Teirstein, Paul S

Valencia, Rafael; Price, Matthew J; Sawhney, Neil; Lee, Steve S; Wong, Garrett B; Gollapudi, Raghava R; Banares, Michelle; Schatz, Richard A; Teirstein, Paul S.

Affiliation

Valencia R; Department of Cardiovascular Diseases, Scripps Clinic, La Jolla, California.

Am J Cardiol ; 100(7): 1099-102, 2007 Oct 01.

Article in En | MEDLINE | ID: mdl-17884370

Subject(s)

Angioplasty, Balloon, Coronary; Anticoagulants/therapeutic use; Coronary Artery Disease/therapy; Platelet Aggregation Inhibitors/therapeutic use; Adolescent; Adult; Aged; Aged, 80 and over; Aspirin/therapeutic use; Clopidogrel; Coronary Artery Disease/drug therapy; Drug Therapy, Combination; Eptifibatide; Female; Heparin/therapeutic use; Humans; Male; Middle Aged; Peptides/therapeutic use; Pilot Projects; Prospective Studies; Pyridines/therapeutic use; Ticlopidine/analogs & derivatives; Ticlopidine/therapeutic use; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Coronary Artery Disease / Platelet Aggregation Inhibitors / Angioplasty, Balloon, Coronary / Anticoagulants Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Am J Cardiol Year: 2007 Type: Article

Search on Google

XML

PubMed Links